Cboe CA - Delayed Quote CAD
Cybin Inc. (CYBN.NE)
9.80
+0.66
+(7.22%)
At close: May 9 at 3:38:11 PM EDT
Research Analysis
Earnings Estimate
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 5 |
| Avg. Estimate | -1.22 | -1.24 | -3.85 | -5.16 |
| Low Estimate | -1.47 | -1.48 | -5.52 | -6.51 |
| High Estimate | -0.72 | -0.76 | -0.56 | -3.59 |
| Year Ago EPS | -0.76 | -0.76 | -9.5 | -3.85 |
Revenue Estimate
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in CAD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.52 | -1.33 | -0.91 | -1.57 |
| EPS Actual | -0.76 | -0.76 | -2.86 | -0.53 |
| Difference | 0.76 | 0.57 | -1.95 | 1.04 |
| Surprise % | 50.00% | 42.86% | -215.19% | 66.19% |
EPS Trend
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.22 | -1.24 | -3.85 | -5.16 |
| 7 Days Ago | -1.19 | -1.47 | -4.95 | -5.98 |
| 30 Days Ago | -1.38 | -1.46 | -4.49 | -5.94 |
| 60 Days Ago | -1.38 | -1.46 | -4.49 | -5.94 |
| 90 Days Ago | -1.38 | -1.46 | -4.49 | -5.94 |
EPS Revisions
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | 1 |
| Up Last 30 Days | 2 | 3 | 2 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 2 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CYBN.NE | -59.89% | -62.53% | 59.47% | -33.92% |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Initiated | Guggenheim: Buy | 3/13/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/13/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 2/12/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/27/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 11/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/19/2024 |
Related Tickers
PHRM.CN PharmaTher Holdings Ltd.
0.2150
-2.27%
MDMA.CN Pharmala Biotech Holdings Inc.
0.1500
+15.38%
ATAI Atai Life Sciences N.V.
1.3900
-0.71%
MNMD Mind Medicine (MindMed) Inc.
6.15
-4.80%
ONC.TO Oncolytics Biotech Inc.
0.7100
-1.39%
PHRRF PharmaTher Holdings Ltd.
0.1523
-4.81%
1KA.MU GH Research PLC
9.40
0.00%
DRUG.CN Bright Minds Biosciences Inc.
45.24
+2.40%
BETR.CN BetterLife Pharma Inc.
0.0850
-10.53%
MDNA.TO Medicenna Therapeutics Corp.
1.0600
+6.00%